Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00899626 · ClinicalTrials.gov registry record

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

A clinical trial of Colorectal Cancer and Pancreatic Cancer, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
5,000
Enrollment target
2
Study locations

NCT00899626: Recruiting study of Colorectal Cancer and Pancreatic Cancer, sponsored by Vanderbilt University Medical Center.

NCT00899626 is a study of Colorectal Cancer and Pancreatic Cancer that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 5,000 participants, above the 1,532-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (226% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00899626, a study of Colorectal Cancer and Pancreatic Cancer, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
5,000 participants
Enrollment target
2
Study locations

Study Summary

RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.

Primary Outcome

Genomic and proteomic biomarkers

Study Locations (2)

Tennessee

  • Veterans Affairs Medical Center - Nashville - Nashville
  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2002-06
Est. Completion 2045-10

What NCT00899626 shows while recruiting

NCT00899626 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,532-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (226% higher).

The record links to 5 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00899626 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00899626 about?

NCT00899626 is a clinical study titled "Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients". RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at g...

What is the current status of trial NCT00899626?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2002-06. Estimated completion is 2045-10.

What conditions does trial NCT00899626 study?

This clinical trial studies the following conditions: Colorectal Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Precancerous Condition.

Who is sponsoring clinical trial NCT00899626?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00899626 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00899626's enrollment target sits among peer trials

5,000 18th of 381 higher than 362 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00899626, the US trial registry maintained by the National Library of Medicine. NCT00899626 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.